Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic testAnath C. Lionel, Peter N. Ray, Gregory Costain et al.|Genetics in Medicine|2017Cited by 563
A large data resource of genomic copy number variation across neurodevelopmental disordersMehdi Zarrei, Xudong Liu, Christie L. Burton et al.|npj Genomic Medicine|2019Cited by 199
Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage over standard clinical genetic testingGregory Costain, Christian R. Marshall|European Journal of Human Genetics|2018Cited by 131
Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort studyAlissa M. D’Gama, Amy McTague, Tayyaba Khan et al.|The Lancet Neurology|2023Cited by 74
Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapyFrancisco del Caño‐Ochoa, Santiago Ramón‐Maiques, Bobby G. Ng et al.|Genetics in Medicine|2020Cited by 27